What you need to know about bird flu
On Point | Podcast
Deep Dive
What is the current status of H5N1 bird flu in the United States?
As of now, there have been 66 human cases of H5N1 in the U.S., with 65 of those cases resulting in conjunctivitis (eye redness) and no severe respiratory symptoms. The virus has primarily affected farmworkers, particularly those in the dairy and poultry industries. There has been no documented human-to-human transmission, and the risk to the general public is considered low.
Why is H5N1 considered a significant concern despite its low human transmission?
H5N1 is highly adaptable and has caused major pandemics in the past. It has shown the ability to jump between species, including from birds to mammals like cows and cats. The virus can evolve rapidly, and if it gains the ability for efficient human-to-human transmission, it could lead to a severe pandemic. The current strain has already caused significant losses in the poultry industry and is affecting dairy cows, raising concerns about food supply chains.
How did H5N1 spread to dairy cows, and why is this unusual?
H5N1 likely spread to dairy cows through a single event involving wild birds, possibly in Texas. This is unusual because cows are not typical hosts for avian influenza. The virus has shown a unique tropism for the mammary glands of cows, leading to high viral loads in milk. This has created new routes of transmission, including to farmworkers and other animals like cats.
What are the risks associated with raw milk in the context of H5N1?
Raw milk from infected cows contains high levels of the H5N1 virus, making it a significant risk for transmission. While no human cases have been definitively linked to raw milk consumption, there have been severe cases in animals, including cats, that consumed raw milk or raw pet food. Public health officials strongly advise against consuming raw milk to prevent potential infection.
What measures are being taken to control the spread of H5N1 in the poultry industry?
The U.S. Department of Agriculture has implemented measures such as culling infected flocks and requiring biosecurity checks before restocking farms. Farms with tight biosecurity measures, including disinfectant baths and controlled environments to prevent wild bird contact, are less likely to experience outbreaks. However, the virus continues to spread, particularly along migratory bird routes.
What is the potential for H5N1 to cause a human pandemic?
While H5N1 has not yet shown efficient human-to-human transmission, its ability to infect multiple mammal species and its high mutation rate make it a potential pandemic threat. Public health officials are closely monitoring the virus for changes that could increase its transmissibility or severity in humans. Vaccines and antiviral medications are being prepared as a precaution.
How is the CDC responding to the H5N1 outbreak compared to COVID-19?
The CDC has taken a more proactive and nimble approach to H5N1, leveraging lessons learned from COVID-19. They have updated testing guidance, increased surveillance, and prepared vaccines and antiviral medications. The agency is also focusing on clear communication and adapting its response as new data emerges, aiming to avoid the missteps seen during the early stages of the COVID-19 pandemic.
What is the fatality rate of H5N1 globally, and why is it lower in the U.S.?
Globally, H5N1 has a fatality rate of up to 50% in some outbreaks. In the U.S., however, cases have been milder, likely due to better surveillance catching mild cases, lower viral exposure doses in farmworkers, and differences in how the virus is transmitted. The CDC is closely monitoring for any changes in severity or transmissibility.
What role do migratory birds play in the spread of H5N1?
Migratory birds are a major vector for H5N1, spreading the virus along flyways, such as the Pacific Flyway in the U.S. This has led to periodic outbreaks in poultry and, more recently, in dairy cows. The virus's ability to persist in wild bird populations makes it difficult to control and increases the risk of spillover into other species.
What is the status of H5N1 vaccines for humans?
The CDC has approximately 5 million doses of an H5N1 vaccine, with another 5 million in production. These vaccines are based on circulating strains and are being tested for effectiveness against new variants. While not yet licensed for widespread use, they are part of a preparedness strategy in case the virus evolves to pose a greater threat to humans.
Shownotes Transcript